证券日报网讯湖北宜化（000422）9月2日在互动平台回答投资者提问时表示，公司以践行"长江大保 护"、落实沿江1公里化工企业"关改搬转"任务为契机，已关停宜昌旧厂区的氯碱装置，并在宜昌市田家 河化工园区投资建设氯碱新能源项目，承接并扩充烧碱产能，以液氯和高纯盐酸替代PVC产品，配套园 区下游化工产品，进一步提升公司的盈利能力和市场竞争力。 ...

Core Viewpoint - The company reported a revenue of 1.435 billion yuan for 2024, a year-on-year increase of 10.44%, but faced a significant net loss of 180 million yuan, a decline of 1,311.61% compared to the previous year. The company turned profitable in Q1 2025 with a revenue of 370 million yuan, a year-on-year increase of 12.17% and a net profit of 43.5 million yuan [1][2]. Group 1: Financial Performance - In 2024, the company's gross margin was 19.23%, down 4.39 percentage points year-on-year, and the net margin was -13.34%, down 14.12 percentage points year-on-year [2]. - The company incurred a goodwill impairment of 144 million yuan and other asset impairments totaling 24.93 million yuan, reducing profits by 169 million yuan [2]. - In Q1 2025, the gross margin improved to 23.05%, up 1.65 percentage points year-on-year, and the net margin was 14.29%, an increase of 18.35 percentage points year-on-year [2]. Group 2: Product Performance - The high-purity chemicals segment generated revenue of 778 million yuan in 2024, a year-on-year increase of 11.85%, with a sales volume of 252,400 tons, up 16.83% year-on-year [3]. - High-purity sulfuric acid and high-purity hydrogen peroxide achieved record sales volumes in 2024, with high-purity hydrogen peroxide revenue nearing 350 million yuan, a growth of nearly 15% [3]. - The company is one of the few globally that master the technology for G5 grade high-purity chemicals, supplying over 20 major semiconductor manufacturers domestically [3]. Group 3: Business Development - The company's photoresist segment achieved revenue of 198 million yuan in 2024, a year-on-year increase of 27.61%, with a sales volume of 1,388 tons, up 27.93% year-on-year [4]. - The lithium battery materials segment reported revenue of 260 million yuan, a decline of 5.28% year-on-year, despite a sales volume increase of 15.75% [4]. - The company is expanding its NMP production capacity with a new 60,000-ton production line under construction, which is expected to significantly enhance its output [4]. Group 4: Future Outlook - The company anticipates a gradual improvement in its high-purity chemical layout, maintaining a buy rating despite adjusting profit forecasts for 2025-2027, expecting net profits of 76 million, 112 million, and 155 million yuan respectively [5].

本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 报告摘要 事件1： 高纯化学品和光刻胶持续放量，大额商誉减值及新增折旧拖累24年业绩 点击注册小程序 查看完整报告 特别申明： 公司发布2024年年报。2024年，公司实现营收14.35亿元，同比增长10.44%；实现归母净利润-1.80亿元， 同比减少1312%；实现扣非后归母净利润-1.71亿元，同比减少491%。2024Q4，公司单季度实现营收3.75 亿元，同比增长10.11%，环比增长2.21%；实现归母净利润-1.80亿元，同比亏损扩大2265%，环比由盈转 亏。 事件2： 公司发布2025年一季报。2025Q1，公司单季度实现营收3.70亿元，同比增长12.17%，环比减少1.27%；实 现归母净利润4350万元，同比增长582%，环比扭亏为盈。 点评： 拟发行股 ...